Real Time Molecular Analysis of Breast Cancer Receiving Neo-adjuvant Chemotherapy

RecruitingOBSERVATIONAL
Enrollment

150

Participants

Timeline

Start Date

November 3, 2022

Primary Completion Date

December 31, 2027

Study Completion Date

January 31, 2030

Conditions
Breast Cancer Female
Interventions
OTHER

molecular analysis of blood and tumor

RNAseq, DNAseq, CTCs

Trial Locations (1)

13009

RECRUITING

Institut Paoli-Calmettes, Marseille

All Listed Sponsors
lead

Institut Paoli-Calmettes

OTHER